Navigation Links
Matthew B. Wiener, CEO of Pharmatech, Inc., Is Awarded the Cancer Leadership Award From the Colorado Cancer Coalition
Date:10/2/2008

DENVER, Oct. 2 /PRNewswire/ -- Matthew B. Wiener, PharmD, Chief Executive Officer of Pharmatech, Inc., was recently awarded the Outstanding Cancer Leadership Award from the Colorado Cancer Coalition. The award is being presented to Dr. Wiener for his development of the Just-In-Time (JIT) enrollment methodology for cancer clinical trials. Dr. Wiener will accept his award on the evening of October 6th, at the St. Mary's Cancer Center, which will take place during the Colorado Cancer Summit, October 6th and 7th, in Grand Junction, Colorado.

The Just-In-Time methodology has been utilized at various Pharmatech research network sites within the state of Colorado as a means to increase enrollment in cancer clinical trials for rare disease indications. The JIT strategy puts the patient first in regards to enrolling into a clinical trial, as cancer patients are treated in a more efficient manner and drug sponsors see their trials completed in a shorter time frame. Matthew Wiener states that, "It is a high honor to receive such a distinguished award from the Colorado Cancer Coalition. Their recognition of our JIT program gives the program clout within the pharmaceutical and bioscience industries."

Matthew Wiener has dedicated the past 20 years to clinical research and his JIT program has been featured in abstracts and poster presentations at annual meetings, including the American Society of Clinical Oncology (ASCO) and the American Society of Hematology (ASH).

About Pharmatech, Inc.:

Pharmatech, headquartered in Denver, Colorado, is a Research Management Organization (RMO) dedicated to the highest quality of clinical research. Pharmatech provides services of a Site Management Organization (SMO) and a Contract Research Organization (CRO) with a focus in oncology clinical trials. Through an organized research network, the Company focuses on the development and utilization of therapeutic products among sponsors, investigators, and patients. For more information about Pharmatech, please visit http://www.pharmatech.com.

Key Words: Oncology, Clinical Trials, Cancer Patients, CRO, SMO, Just-In-Time, Colorado


'/>"/>
SOURCE Pharmatech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
2. Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing
3. Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greeces Leading Biotech Magazine
4. Matthew B. Potter Joins Pressure BioSciences, Inc. as Vice President of Sales
5. Neurobiological Technologies Appoints Matthew M. Loar as Chief Financial Officer
6. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
7. Cord Blood America CEO Matthew Schissler Says Operations Significantly Streamlined
8. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
9. BSP Pharma Inc., Makers of FlexNow(TM) Joint Formula Sign Distribution Deal with Vitamin Shoppe and GNC
10. The PLSG Invests $150,000 in Coventina Healthcare Enterprises, Inc., Its Eighth Company Relocation to Pittsburgh
11. Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2017)... Baltimore, Maryland (PRWEB) , ... August 21, 2017 ... ... has partnered with a leading Chinese bio security firm, to bring its proprietary ... As part of the relationship, the Chinese firm has purchased an undisclosed ...
(Date:8/18/2017)... ... August 18, 2017 , ... OAI, a leading Silicon ... Microfluidics Industries, announces the new Model 800E front and backside, semi-automatic mask aligner ... mask aligners. OAI has already received and installed several orders for the ...
(Date:8/16/2017)... ... August 16, 2017 , ... Recent ... cell type. Many treatments for specific cancers, such as breast, prostate, or lung, ... is androgen deprivation therapy for advanced prostate cancer. , This therapy limits ...
(Date:8/16/2017)... OXFORD, England , Aug. 16, 2017  Kingfisher Talent, ... search and leadership development, and Virdis Group, global executive search ... exclusive alliance that enables clients to leverage the expertise and ... "For our clients here in the Boston ... diverse population of leadership talent throughout the US, ...
Breaking Biology Technology:
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
(Date:5/23/2017)... first robotic gym for the rehabilitation and functional motor sense evaluation of ... Italy . The first 30 robots will be available from June ... . The technology was developed and patented at the IIT laboratories and ... thanks to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):